Genesis Care Oxford

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Metastatic breast cancer1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Kartos Therapeutics, Inc.1 trial
• MedSIR1 trial

Running trials

• Recruiting

  Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.

  NCT06382948· Phase 3· MedSIR· Source

  Contact: Mark Tthill, MD

• Recruiting

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· Phase 3· Kartos Therapeutics, Inc.· Source

  Contact: John Mei

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Metastatic breast cancer1 recruiting
• Myeloproliferative neoplasms1 recruiting